Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Prostate Cancer, nmCRPC

Cora Sternberg

MD

🏢Weill Cornell Medicine🌐USA

Clinical Director, Englander Institute for Precision Medicine

56
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Cora Sternberg is a world-renowned genitourinary oncologist and co-investigator of the PROSPER trial that established enzalutamide for nmCRPC. She has pioneered systemic therapy approaches across bladder, kidney, and prostate cancers and has held leadership positions at leading European and American cancer centers. Her expertise spans clinical trial design, biomarker development, and international oncology collaboration. Sternberg is a recipient of numerous distinguished service awards in oncology.

Share:

🧪Research Fields 研究领域

PROSPER trial
nmCRPC enzalutamide
metastasis-free survival
prostate cancer systemic therapy
CRPC treatment sequencing

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Cora Sternberg 的研究动态

Follow Cora Sternberg's research updates

留下邮箱,当我们发布与 Cora Sternberg(Weill Cornell Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment